Fentanyl Citrate

Fentanyl Citrate · FENTANYL CITRATE 50 ug/mL · Injection, Solution · Intramuscular; Intravenous · Hospira, Inc.

NDC 00409-9094-55 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.7%chance of a new FDA shortage posting for fentanyl citrate (injectable) in the next 90 days

sterile injectable · price up 70% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 5× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Hospira, Inc.United States
analysis · label · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 3 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $1,737.20 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application: NDA019115
TE code: AP
Approval date: Jan 12, 1985
Patents / exclusivity: None on file

Shortage history

In shortage now — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)Jan 1, 2012
Other
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
In shortage now — Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)Jan 1, 2012
month 177 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fentanyl Citrate (Injection, Solution)

Labeler	Strength	First seen	Last seen
Bond Pharmacy INC	FENTANYL CITRATE 10 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	FENTANYL CITRATE .05 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	FENTANYL CITRATE 100 ug/2mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	FENTANYL CITRATE 50 ug/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	FENTANYL CITRATE 50 ug/mL	Jul 15, 2026	Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fentanyl Citrate — NDC 00409-9094-55," retrieved September 3, 2026, https://drugdashboards.com/drug/00409909455.

Free to cite with attribution — see how the data is put together.